Bing-E Xu, PhD; Bruce A. Feinberg, DO; Monica Lingam, MS
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...
Rakesh Luthra, MS; Jonathan Graham, BS; Stephanie Earnshaw, PhD; Rohit Borker, PhD; Jonathan Lim, BS, MS, MSc
Abstract: A decision model was developed to compare the cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) with epidermal...
Abstract: A decision model was developed to compare the cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) with epidermal...
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done.
During 2010 and 2011, the news headlines were filled with...
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done.
During 2010 and 2011, the news headlines were filled with...
Shortages of life-saving chemotherapy agents and supportive care drugs have presented physicians treating children with cancer with difficult decisions regarding drug allocation and prioritization. Guidelines...
Shortages of life-saving chemotherapy agents and supportive care drugs have presented physicians treating children with cancer with difficult decisions regarding drug allocation and prioritization. Guidelines...
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out...
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out...
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD; Seth Gordon, MBA; Scott Guerin, PhD
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...
Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...
As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...
As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...
A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as...
A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as...
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...